Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles

PURPOSE: Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer. Lipid–polymer hybrid nanoparticles (LPNs) combine the advantages of both polymeric nanoparticles and liposomes into a single delivery platform. In this study, we engineered LPNs as the co-delivery system of paclita...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Cheng, Hao, Han, Le, Qiang, Zhun, Zhang, Xinwei, Gao, Wei, Zhao, Kun, Song, Yangrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161729/
https://www.ncbi.nlm.nih.gov/pubmed/30288024
http://dx.doi.org/10.2147/DDDT.S172199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161729/
https://www.ncbi.nlm.nih.gov/pubmed/30288024
http://dx.doi.org/10.2147/DDDT.S172199

Ejemplares similares